St. Vincent’s hospital became the first in the state to successfully implant a new technology that helps circulate blood flow ...

Rapamycin is typically prescribed to organ transplant patients to suppress their immune systems. But many scientists and ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Researchers have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated. Their findings suggest a potential ...

Belzutifan improved progression-free survival and objective response rate compared to everolimus in previously treated ...

Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

Continued use of systemic glucocorticoids, a calcineurin inhibitor (tacrolimus or cyclosporine), or a mammalian target of rapamycin (mTOR) inhibitor (sirolimus or everolimus) that the patient was ...

Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk. So, if you had invested in Boston Scientific a ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...